Not Signed In -
Vinorelbine Tartrate |
Navelbine |
Vinorelbine Systematic (IUPAC) name 4-(acetyloxy)-6,7-didehydro-15- ((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro- 8-(methoxycarbonyl)-2,6-methano- 2H-azecino(4,3-b)indol-8-yl)-3-hydroxy- 16-methoxy-1-methyl-,methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)- aspidospermidine-3-carboxylic acid Identifiers CAS number 71486-22-1 ATC code L01CA04 PubChem 60780 DrugBank APRD00101 Chemical data Formula C45H54N4O8 Mol. weight 778.932 g/mol Pharmacokinetic data Bioava ...
Wikipedia - [full article]
Vinorelbine Tartrate Clinical Trials
- A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
ClinicalTrials.gov Identifier: NCT00432562 - Completed
Breast Cancer; Non-Small Cell Lung Cancer; Non-Hodgkins Lymphoma
- Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
ClinicalTrials.gov Identifier: NCT00026494 - Active, not recruiting
brain metastases
- Vinorelbine in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003259 - Active, not recruiting
stage IV prostate cancer
- Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00006088 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
ClinicalTrials.gov Identifier: NCT00003902 - Active, not recruiting
stage IV breast cancer
- Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00049660 - Active, not recruiting
stage IV breast cancer
- Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00075673 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Vinorelbine in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003828 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
Prostate Cancer
- Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006682 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- AN OPEN-LABEL PHASE I STUDY OF WEEKLY ABI-007 AND VINORELBINE WITH OR WITHOUT G-CSF IN PATIENTS WITH STAGE IV (METASTATIC) BREAST CANCER
ClinicalTrials.gov Identifier: NCT00140140 - Active, not recruiting
Stage IV (Metastatic) Breast Cancer
- Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003730 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00003622 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00041067 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00070304 - Active, not recruiting
recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
- Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed
ClinicalTrials.gov Identifier: NCT00002583 - Active, not recruiting
stage II non-small cell lung cancer; Quality of Life; stage I non-small cell lung cancer
- Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00194727 - Active, not recruiting
Breast Neoplasm
- A Phase II Trial of Doxil and Multiday Vinorelbine in Patients with Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00159094 - Recruiting
Metastatic breast cancer
- Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
ClinicalTrials.gov Identifier: NCT00383643 - Recruiting
Chronic Insomnia
- Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00079287 - Active, not recruiting
Adenocarcinoma of the Lung; large cell lung cancer; recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; ...
- Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003447 - Active, not recruiting
stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00054197 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00193089 - Active, not recruiting
Breast Cancer
- Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery
ClinicalTrials.gov Identifier: NCT00057798 - Active, not recruiting
stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00242983 - Active, not recruiting
Lung Cancer
- A 12-Week Double-Blind, Placebo-Controlled, Multicenter Study with Varenicline Tartrate 1mg Bid for Smoking Cessation
ClinicalTrials.gov Identifier: NCT00155298 - Recruiting
Smoking
- Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00093808 - Recruiting
recurrent breast cancer; stage IV breast cancer; Male Breast Cancer
- Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00005865 - Active, not recruiting
stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00006215 - Active, not recruiting
stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Effects of G-CSF, Trastuzumab, and Vinorelbine on Immune Cell Function
ClinicalTrials.gov Identifier: NCT00169104 - Recruiting
Metastatic Breast Cancer
- Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
ClinicalTrials.gov Identifier: NCT00226096 - Active, not recruiting
CVA (Cerebrovascular Accident); Cerebral Hemorrhage; Intracranial Hemorrhages
- Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00004096 - Active, not recruiting
stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00309998 - Active, not recruiting
Lung Cancer
- Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00544765 - Active, not recruiting
Breast Cancer
- Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00193362 - Active, not recruiting
Lung Cancer
- Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
ClinicalTrials.gov Identifier: NCT00002949 - Active, not recruiting
stage III bladder cancer; stage III endometrial cancer; stage II bladder cancer; stage II cervical cancer; stage III cervical cancer; ...
- Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00253591 - Active, not recruiting
Lung Cancer
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00088985 - Recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Randomized Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With NSCLC
ClinicalTrials.gov Identifier: NCT00441922 - Recruiting
Non Small Cell Lung Cancer
- Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00325234 - Recruiting
Breast Neoplasms
- Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma
ClinicalTrials.gov Identifier: NCT00403988 - Recruiting
Breast Neoplasms
- Docetaxel and Vinorelbine Plus Sargramostim in Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00256282 - Recruiting
Metastatic Melanoma
- Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
ClinicalTrials.gov Identifier: NCT00180947 - Recruiting
Rhabdomyosarcomas; Neoplasms, Connective and Soft Tissue; Ewing Tumor; Osteosarcomas; Neuroblastomas; Medulloblastomas
- Bortezomib, Ifosfamide, and Vinorelbine in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
ClinicalTrials.gov Identifier: NCT00381940 - Recruiting
Lymphoma
- Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00389922 - Recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With NSCLC
ClinicalTrials.gov Identifier: NCT00441740 - Recruiting
Non Small Cell Lung Cancer
- Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
ClinicalTrials.gov Identifier: NCT00041470 - Active, not recruiting
Breast Cancer
- Metronomic Oral Vinorelbine in Patients With Metastatic Tumors
ClinicalTrials.gov Identifier: NCT00278070 - Recruiting
Breast Cancer; Non Small Cell Lung Cancer; Prostate Cancer
- Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
ClinicalTrials.gov Identifier: NCT00540982 - Recruiting
Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00266110 - Recruiting
Breast Cancer
- Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00513058 - Recruiting
Breast Cancer
- Randomized Phase III Study With Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00431106 - Recruiting
Breast Cancer
- Vinorelbine (Oral) Plus Trastuzumab for 1st-Line Treatment of HER2/Neu Overexpressing Breast Cancer
ClinicalTrials.gov Identifier: NCT00433095 - Recruiting
Metastatic Breast Cancer
- VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00431704 - Recruiting
Metastatic Breast Cancer
- Combination Chemotherapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00004105 - Active, not recruiting
childhood soft tissue sarcoma; Leukemia; Lymphoma
- Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00309972 - Recruiting
Lung Cancer
- Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00372476 - Recruiting
Breast Cancer
- Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00006372 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00480597 - Active, not recruiting
Metastatic Breast Cancer
- Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00002887 - Active, not recruiting
recurrent non-small cell lung cancer
- Genome-Guided Adjuvant Cisplatin With Either Vinorelbine or Pemetrexed for Early Stage Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00545948 - Recruiting
Carcinoma, Non-Small-Cell Lung
- Randomized Phase II Study With Docetaxel,Carboplatin and Herceptin vs Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
ClinicalTrials.gov Identifier: NCT00453635 - Recruiting
Breast Cancer
- Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
ClinicalTrials.gov Identifier: NCT00002813 - Active, not recruiting
recurrent cervical cancer; cervical squamous cell carcinoma
- Vinorelbine+Trastuzumab vs Docetaxel+Trastuzumab as 1. Line Treatment for HER2+ Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00430001 - Recruiting
Metastatic Breast Neoplasm
- Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00030459 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006114 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003400 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Combined Behavioral/Pharmacological Therapy for Insomnia
ClinicalTrials.gov Identifier: NCT00044629 - Recruiting
Sleep Initiation and Maintenance Disorders; Sleep Deprivation
- A Phase II Study of Gemcitabine in Combination With Vinorelbine vs. Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00532623 - Completed
Breast Cancer; Metastatic
- Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00004237 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00176488 - Recruiting
Breast Cancer
- Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00075699 - Active, not recruiting
epithelial mesothelioma; localized malignant mesothelioma; advanced malignant mesothelioma
- Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00003963 - Active, not recruiting
Waldenstrom's Macroglobulinemia; adult non-Hodgkin's lymphoma
- Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00272558 - Recruiting
Malignant Pleural Mesothelioma
- Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00576914 - Recruiting
Non-Small Cell Lung Cancer
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
ClinicalTrials.gov Identifier: NCT00283790 - Completed
Insomnia
- Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease
ClinicalTrials.gov Identifier: NCT00364676 - Recruiting
Tumors; Hodgkins Disease; Non-Hodgkins Lymphoma
- Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00006760 - Active, not recruiting
recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
- Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003584 - Active, not recruiting
Stage IV Renal Cell Cancer; childhood kidney/urinary cancer; recurrent renal cell cancer
- Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
ClinicalTrials.gov Identifier: NCT00413751 - Completed
Healthy
- A Study of Zolpidem Tartrate Lozenge in Adult Patients With Insomnia
ClinicalTrials.gov Identifier: NCT00466193 - Completed
Sleep Initiation and Maintenance Disorders
- Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
ClinicalTrials.gov Identifier: NCT00064077 - Active, not recruiting
cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; recurrent cervical cancer; ...
- P-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors
ClinicalTrials.gov Identifier: NCT00011414 - Recruiting
Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00004093 - Active, not recruiting
stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00005825 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Trastuzumab in Combination with Vinorelbine or Taxane-Based Chemotherapy in Patients with Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00146549 - Completed
Breast Cancer; Stage IV Breast Cancer
- A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients with Open-Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00061529 - Completed
Open-Angle Glaucoma; Ocular Hypertension
- Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00014430 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00002823 - Active, not recruiting
stage III non-small cell lung cancer; Adenosquamous Cell Lung Cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; ...
- Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003240 - Active, not recruiting
stage III non-small cell lung cancer; stage IV non-small cell lung cancer; stage II non-small cell lung cancer; stage I non-small cell lung cancer
- Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003587 - Active, not recruiting
stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer; ...
- Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003159 - Active, not recruiting
stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
- Efficacy and Tolerability of DITROPAN® XL (Oxybutynin Chloride) Versus DETROL® LA (Tolterodine Tartrate) in Treatment of Overactive Bladder
ClinicalTrials.gov Identifier: NCT00293839 - Completed
Urinary Incontinence
- Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00004100 - Active, not recruiting
childhood thorax/respiratory cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; Quality of Life
- An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
ClinicalTrials.gov Identifier: NCT00371813 - Completed
Smoking
- Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00055887 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; ...
- Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients with Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00148291 - Completed
Lung Cancer
- Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00103233 - Completed
stage IV breast cancer; recurrent breast cancer
- Vinorelbine in Treating Older Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00022152 - Completed
stage IV breast cancer; recurrent breast cancer
Resources
- Navelbine (Drug Digest)
- Vinorelbine Tartrate (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
